Fentanyl Patch Sufficient Analgesia for Only One Day

Journal of Pain and Symptom Management

Volumn 31, Issue 5, 2006, Pages 389-390

  Sasson, Menahem ^a   Shvartzman, Pesach ^a  

^a BEN GURION UNIVERSITY OF THE NEGEV   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; BICALUTAMIDE; FENTANYL; HYDROCHLOROTHIAZIDE; LEVOTHYROXINE SODIUM; MORPHINE; OXCARBAZEPINE;

AGED; ANALGESIA; BONE PAIN; CASE REPORT; CONVULSION; DEMENTIA; DOSE RESPONSE; DRUG SUBSTITUTION; DRUG WITHDRAWAL; HOME CARE; HOSPITAL ADMISSION; HUMAN; HYPERTENSION; HYPOTHYROIDISM; LETTER; MALE; PALLIATIVE THERAPY; PELVIS PAIN SYNDROME; PROSTATE CANCER; PRURITUS; STROKE; TABLET;

ADMINISTRATION, CUTANEOUS; AGED; ANALGESICS, OPIOID; BONE NEOPLASMS; FENTANYL; HUMANS; MALE; PAIN; PALLIATIVE CARE; PROSTATIC NEOPLASMS;

EID: 33646593534     PISSN: 08853924     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jpainsymman.2005.12.015     Document Type: Letter

References (6)

1. Muijsters B.R., and Wagstaff A.J. Transdermal fentanyl: an updated review of its pharmacological properties and therapeutic efficacy in chronic cancer pain control. Drugs 61 (2001) 2289-2307
2. Allan L., Hays H., Jensen N.H., et al. Randomised crossover trial of transdermal fentanyl and sustained release oral morphine for treating chronic non-cancer pain. Br Med J 322 (2001) 1154-1558
3. FDA consumer updates 2005;39:3.
4. Radbuch L., Sabatowski R., Petzke F., Radbruch A.B., and Grond S. Transdermal fentanyl for the management of cancer pain: a survey of 1005 patients. Palliat Med 15 (2001) 309-321
5. Fentanyl citrate. Mosby's drug consult (2005), Mosby, Inc. www.mdconsult.com
6. Ahmedzai S., and Brooks D. Transdermal fentanyl versus sustained-release oral morphine in cancer pain: preference, efficacy and quality of life. TTS-Fentanyl Comparative Trial Group. J Pain Symptom Manage 13 (1997) 254-261